This interview reviews the current challenges to patients and their care teams and highlights how advancing technologies can facilitate the delivery of care.
One such technology is Aptar Pharma’s HeroTracker® Sense. This innovation has the potential to reduce the burden of chronic respiratory diseases on HCPs, nurse practitioners and patients. This novel connected healthcare device transforms a standard metered dose inhaler into a connected healthcare device. It provides valuable feedback to patients to help them use their pMDI as intended and supports their inhalation technique. It also provides valuable analytics to the HCP and insights into patient training and onboarding, thereby helping care teams to better understand real-life situations and use of pMDIs, and adapt treatment plans accordingly.
Learn more about Aptar Pharma’s expertise in Digital Health
This Might Also Be of Interest
Digital Health and Oncology Innovations in Subcutaneous Administration
Publications, Pharmaceutical, Product Solutions, Device Innovations, Market Insights
Elevating Medication Adherence and Clinical Outcomes with Connected Drug Delivery
Publications, Pharmaceutical, Device Innovations, Brand Differentiation, Market Insights, Product Solutions
Patient-Focused Cancer Care: Harnessing Immunotherapy
Publications, Pharmaceutical, Device Innovations, Market Insights, Product Solutions
The Potential of Digital Health in Empowering Patients with Cancer
Webinars, Pharmaceutical, Product Solutions, Device Innovations, Brand Differentiation, Market Insights
